Matches in Wikidata for { <http://www.wikidata.org/entity/Q64396619> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q64396619 description "clinical trial" @default.
- Q64396619 description "ensayu clínicu" @default.
- Q64396619 description "klinisch onderzoek" @default.
- Q64396619 description "клінічне випробування" @default.
- Q64396619 name "Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection" @default.
- Q64396619 type Item @default.
- Q64396619 label "Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection" @default.
- Q64396619 prefLabel "Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection" @default.
- Q64396619 P1050 Q64396619-6712A53D-14AC-4A5A-9FBF-CC8D3C9B9A68 @default.
- Q64396619 P1050 Q64396619-B6ECF654-4D47-4EFC-915B-0D9B42DB8D7C @default.
- Q64396619 P1132 Q64396619-7A4AA1B9-3272-4F86-AE93-2A283305FB14 @default.
- Q64396619 P1476 Q64396619-52B0818C-434B-47FE-8BCC-E86C56E89051 @default.
- Q64396619 P17 Q64396619-682898EB-852E-4A88-B7E0-A55513E09A3B @default.
- Q64396619 P2899 Q64396619-2BC31E9C-B90E-41C7-8449-E7886F0CEB29 @default.
- Q64396619 P3098 Q64396619-7943F772-EE05-41A3-A182-B4ACDA6E6BC7 @default.
- Q64396619 P31 Q64396619-3AAB9EF7-1A56-4E03-ABBD-90A47A26BCA6 @default.
- Q64396619 P4844 Q64396619-5C2088AA-701A-4DF0-B0A5-DEA7870FEF7B @default.
- Q64396619 P580 Q64396619-DAFA895F-B49D-4709-9E8F-BA0068B4E7DE @default.
- Q64396619 P582 Q64396619-7C9FE06D-AD1D-4F58-A60A-1A7C1FED140B @default.
- Q64396619 P6099 Q64396619-B5449D14-B8F4-4DD1-989B-12E6D3B7B90E @default.
- Q64396619 P8363 Q64396619-50B6A7F4-2CCA-4495-9145-BF7278C8F721 @default.
- Q64396619 P921 Q64396619-C646A5A8-DFE5-42D7-8A00-086C974C36AA @default.
- Q64396619 P1050 Q131742 @default.
- Q64396619 P1050 Q154869 @default.
- Q64396619 P1132 "+111" @default.
- Q64396619 P1476 "A Phase 2 Open- Label Study to Evaluate The Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naïve Patients With Chronic HCV Genotype 3 Infection" @default.
- Q64396619 P17 Q16 @default.
- Q64396619 P2899 "+18" @default.
- Q64396619 P3098 "NCT02413593" @default.
- Q64396619 P31 Q30612 @default.
- Q64396619 P4844 Q2502747 @default.
- Q64396619 P580 "2015-04-01T00:00:00Z" @default.
- Q64396619 P582 "2015-12-01T00:00:00Z" @default.
- Q64396619 P6099 Q42824440 @default.
- Q64396619 P8363 Q78089383 @default.
- Q64396619 P921 Q15409409 @default.